EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Thymic Stromal Lymphopoietin Promotes Proliferation and Contractility of Human Pulmonary Artery Smooth Muscle

Michael Thompson, Martin Helan, Li Drake, Benjamin Roos, Christina M Pabelick iD, Y S Prakash iD

Pulmonary Circulation · 2026-10 · 16 (4)

DOI: 10.1002/pul2.70450 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pulmonary Circulation, online erschienen am 06.11.2026. Verfasst von Michael Thompson und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Perioperative Medicine Mayo Clinic Rochester Minnesota USA. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Mayo Clinic.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypoxia is a well‐recognized risk factor in several pulmonary vascular diseases, including pulmonary hypertension (PH). Furthermore, hypoxia‐associated inflammatory changes enhance the structural and functional changes in the pulmonary artery (PA) of PH patients. Understanding the mechanisms that link hypoxia and inflammation, particularly early in disease, is key to the development of novel therapeutic avenues for PH. Thymic stromal lymphopoietin (TSLP) is an “early” inflammatory mediator thought to be critical in diseases such as asthma, chronic obstructive pulmonary disease, and atopic dermatitis. TSLP has canonical effects on the immune system, but can also have non‐canonical effects on resident lung cells, for example, airway smooth muscle. Currently, the expression and role of TSLP in the PA are unknown. We hypothesized that locally produced TSLP potentiates the effects of hypoxia in PA remodeling and contractility relevant to PH. Experiments in human PA endothelial cells (PAECs) and smooth muscle cells (PASMCs) found PAECs to be a larger source of TSLP, which targets PASMCs to enhance intracellular Ca 2+ responses and contractility to vasoconstrictor agonists, as well as cell proliferation and extracellular matrix deposition, acting via a number of signaling cascades including Stat3 and PI3/Akt. Hypoxia, acting via HIF1α, enhanced PAEC production of TSLP and promoted TSLP effects on PASMCs. Interestingly, TSLP per se enhanced HIF1α. Overall, these novel data highlight a role for TSLP in hypoxia effects on the PA, and thus relevance for inflammation in PH.

Schlagwörter

Stichwörter der Autor:innen

inflammationproliferationpulmonary hypertensionremodelingvasoconstriction

Autor:innen und Institutionen

  • Department of Anesthesiology and Perioperative Medicine Mayo Clinic Rochester Minnesota USA.
  • Department of Physiology and Biomedical Engineering Mayo Clinic Rochester Minnesota USA.
  • Department of Anesthesiology and Intensive Care Brno University Brno Czech Republic.
  • Department of Neurosurgery Brno University Brno Czech Republic.
  • Intensive Care Research Brno University Brno Czech Republic.

ORCID-Profile: Christina M Pabelick, Y S Prakash

Förderung

  • Mayo Clinic

Zitieren

APA

Thompson, M., Helan, M., Drake, L., Roos, B., Pabelick, C. M., & Prakash, Y. S. (2026). Thymic Stromal Lymphopoietin Promotes Proliferation and Contractility of Human Pulmonary Artery Smooth Muscle. Pulmonary Circulation, 16(4). https://doi.org/10.1002/pul2.70450

Vancouver

Thompson M, Helan M, Drake L, Roos B, Pabelick CM, Prakash YS. Thymic Stromal Lymphopoietin Promotes Proliferation and Contractility of Human Pulmonary Artery Smooth Muscle. Pulmonary Circulation. 2026;16(4). doi:10.1002/pul2.70450

BibTeX
@article{Thompson2026,
  author = {Thompson, Michael and Helan, Martin and Drake, Li and Roos, Benjamin and Pabelick, Christina M and Prakash, Y S},
  title = {Thymic Stromal Lymphopoietin Promotes Proliferation and Contractility of Human Pulmonary Artery Smooth Muscle},
  journal = {Pulmonary Circulation},
  year = {2026},
  volume = {16},
  number = {4},
  doi = {10.1002/pul2.70450}
}
Kostenlos starten →